Shares of vaccine makers fell on Thursday as President-elect Donald Trump
nominated
Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human Services.
The stocks fell in the final hour of trading as
reports
emerged about Trump’s expected pick.
Moderna
’s stock closed more than 5% lower on Thursday, shares of
Novavax
fell more than 7% and
Pfizer
’s stock ended more than 2% lower.
Shares of
BioNTech
, the German drugmaker that helped develop a Covid vaccine with Pfizer, closed more than 6% lower. British drugmaker
GSK
, which makes flu shots and several other vaccines, closed roughly 2% lower.
Shares of those companies dipped further in extended trading as Trump confirmed his pick in a post on his platform Truth Social.
Health policy experts have said that a second Trump term could allow Kennedy to elevate anti-vaccine rhetoric, which could deter more Americans from receiving Covid shots and routine immunizations that have for decades saved millions of lives and prevented debilitating illnesses.
More from CNBC
-
The House just voted ‘yes’ on a bill that would increase Social Security checks for some pensioners
-
Dow drops 200 points as postelection rally sputters, Powell signals caution on rate cuts
-
39-year-old makes about $18K/month in passive income without a college degree: My best advice
Pfizer, Moderna and Novavax are still recovering from falling Covid vaccination rates in the U.S., which have dented their profits over the last two years.
Kennedy’s track record as a vaccine skeptic is extensive. He has long made misleading and false statements about the safety of shots, such as claiming that they are linked to autism despite numerous studies going back decades that debunk the association.
Kennedy is the founder of the nonprofit Children’s Health Defense, the most well-funded anti-vaccine organization in the country.
Note: Thank you for visiting our website! We strive to keep you informed with the latest updates based on expected timelines, although please note that we are not affiliated with any official bodies. Our team is committed to ensuring accuracy and transparency in our reporting, verifying all information before publication. We aim to bring you reliable news, and if you have any questions or concerns about our content, feel free to reach out to us via email. We appreciate your trust and support!